Reagents and instruments for immunology, cell biology and molecular biology.
 
> Histone H3, acetylated (Lys9) Blocking Peptide

Histone H3, acetylated (Lys9) Blocking Peptide

Print Print
Please log in

Cat# H5110-13G1-100ul

Size : 100ul

Brand : US Biological

Contact local distributor :


Phone : +1 850 650 7790

H5110-13G1 Histone H3, acetylated (Lys9) Blocking Peptide

Grade
Highly Purified
Applications
IHC
Shipping Temp
Blue Ice
Storage Temp
-20°C

Peptide is used to block Acetyl-Histone H3 (Lys9) Rabbit mAb and Acetyl-Histone H3 (Lys9) Antibody reactivity in immunohistochemistry protocols.

Modulation of chromatin structure plays an important role in the regulation of transcription in eukaryotes. The nucleosome, made up of four core histone proteins (H2A, H2B, H3 and H4), is the primary building block of chromatin (1). The amino-terminal tails of core histones undergo various post-translational modifications, including acetylation, phosphorylation, methylation and ubiquitination (2-5). These modifications occur in response to various stimuli and have a direct effect on the accessibility of chromatin to transcription factors and, therefore, on gene expression (6). In most species, histone H2B is primarily acetylated at Lys5, 12, 15 and 20 (4,7). Histone H3 is primarily acetylated at Lys9, 14, 18 and 23 (2,3). Acetylation at Lys9 appears to have a dominant role in histone deposition and chromatin assembly in some organisms (2,3). Phosphorylation at Ser10, Ser28 and Thr11 of histone H3 is tightly correlated with chromosome condensation during both mitosis and meiosis (8-10). Phosphorylation of Thr3 of histone H3 is highly conserved among many species and is catalyzed by the kinase haspin. Immunostaining with phospho-specific antibodies in mammalian cells reveals mitotic phosphorylation of H3 Thr3 in prophase and its dephosphorylation during anaphase (11).

Quality Control: The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. The peptide blocks Acetyl-Histone H3 (Lys9) (C5B11) Rabbit mAb and Acetyl-Histone H3 (Lys9) Antibody signal in immunohistochemistry.

Directions For Use: For immunohistochemistry, add twice the volume of peptide as volume of antibody used in 100ul total volume. Incubate for a minimum of 30 minutes prior to adding the entire volume to the slide. Recommended antibody dilutions can be found on the relevant product data sheet.

Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Acetyl-Histone H3 (Lys9) Rabbit mAb in the presence of control peptide (left) or Acetyl-Histone H3 (Lys9) Blocking Peptide.

Storage and Stability:
May be stored at 4°C for short-term only. For long-term storage, aliquot and store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Applications
Purity: Highly Purified|Form: Supplied as a liquid in 20 mM potassium phosphate (pH 7.0), 50 mM NaCl, 0.1 mM EDTA, 1 mg/ml BSA and 5% glycerol.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in 20 mM potassium phosphate (pH 7.0), 50 mM NaCl, 0.1 mM EDTA, 1 mg/ml BSA and 5% glycerol.
Purity
Highly Purified
References
(1) Workman, J.L. and Kingston, R.E. (1998) Annu. Rev. Biochem. 67, 545–579. |(2) Hansen, J.C. et al. (1998) Biochemistry 37, 17637–17641. |(3) Strahl, B.D. and Allis, C.D. (2000) Nature 403, 41–45. |(4) Cheung, P. et al. (2000) Cell 103, 263–271. |(5) Bernstein, B.E. and Schreiber, S.L. (2002) Chem. Biol. 9, 1167–1173. |(6) Jaskelioff, M. and Peterson, C.L. (2003) Nat. Cell Biol. 5, 395–399. |(7) Thorne, A.W. et al. (1990) Eur. J. Biochem. 193, 701–713. |(8) Hendzel, M.J. et al. (1997) Chromosoma 106, 348–360. |(9) Goto, H. et al. (1999) J. Biol. Chem. 274, 25543– 25549. |(10) Preuss, U. et al. (2003) Nucleic Acids Res. 31, 878–885. |(11) Dai, J. et al. (2005) Genes Dev. 19, 472–488.